203 related articles for article (PubMed ID: 21829018)
1. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
[TBL] [Abstract][Full Text] [Related]
2. SPP1 polymorphisms associated with HBV clearance and HCC occurrence.
Shin HD; Park BL; Cheong HS; Yoon JH; Kim YJ; Lee HS
Int J Epidemiol; 2007 Oct; 36(5):1001-8. PubMed ID: 17496055
[TBL] [Abstract][Full Text] [Related]
3. Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim YJ; Kim HY; Kim JS; Lee JH; Yoon JH; Kim CY; Park BL; Cheong HS; Bae JS; Kim S; Shin HD; Lee HS
J Viral Hepat; 2010 Jul; 17(7):518-26. PubMed ID: 19780938
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
5. Integrin alpha V polymorphisms and haplotypes in a Korean population are associated with susceptibility to chronic hepatitis and hepatocellular carcinoma.
Lee SK; Kim MH; Cheong JY; Cho SW; Yang SJ; Kwack K
Liver Int; 2009 Feb; 29(2):187-95. PubMed ID: 18694400
[TBL] [Abstract][Full Text] [Related]
6. [Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection].
Kim YJ; Lee HS
Korean J Hepatol; 2009 Mar; 15(1):7-14. PubMed ID: 19346781
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Kim YJ; Lee HS
Intervirology; 2005; 48(1):10-5. PubMed ID: 15785084
[TBL] [Abstract][Full Text] [Related]
9. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
11. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
[TBL] [Abstract][Full Text] [Related]
12. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
13. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence.
Lee DH; Cho Y; Seo JY; Kwon JH; Cho EJ; Jang ES; Kwak MS; Cheong JY; Cho SW; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Shin HD; Kim YJ
Intervirology; 2013; 56(2):84-90. PubMed ID: 23343781
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
Kao JH; Chen PJ; Chen DS
Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
[TBL] [Abstract][Full Text] [Related]
17. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
18. Gene polymorphisms of TLR2 and TLR3 in HBV clearance and HBV-related hepatocellular carcinoma in a Chinese male population.
Chen D; Xie W; Lu Y; Su S; Nong L; Jia Y; Liu Y; Zhou W; Wang H; Tan A
Int J Biol Markers; 2017 May; 32(2):e195-e201. PubMed ID: 28009434
[TBL] [Abstract][Full Text] [Related]
19. Association of DLC1 gene polymorphism with susceptibility to hepatocellular carcinoma in Chinese hepatitis B virus carriers.
Dong X; Zhou G; Zhai Y; Zhang H; Yang H; Zhi L; Zhang X; Chu J; He F
Cancer Epidemiol; 2009 Oct; 33(3-4):265-70. PubMed ID: 19766077
[TBL] [Abstract][Full Text] [Related]
20. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers.
Kong SY; Ki CS; Yoo BC; Kim JW
Cancer Sci; 2008 Feb; 99(2):340-4. PubMed ID: 18271934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
